Viedma-Rodriguez et al. [34] showed BIK as a reliable therapeutic molecule in gene therapy-based approaches to treat cancer, and researchers have found that this suppression of the gene enhances resistance to tamoxifen in MCF-7 breast cancer cells. This evidence concerns the gene BIK and breast carcinoma.